Slaughter and May is advising Johnson Matthey Plc on the sale of its Medical Device Components business

Slaughter and May is advising Johnson Matthey Plc (JM) on the sale of its Medical Device Components business (MDC) to Montagu Private Equity for US$700 million (£550 million) on a cash free, debt free basis.

 

The MDC business comprises JM’s medical devices manufacturing business which operates in the US, Mexico and Australia. The business produces components for medical device manufacturers globally with a focus on precious metal alloys and nitinol. The sale includes the MDC manufacturing sites in San Diego, Mexicali and Tullamarine.

 

The transaction, which is subject to regulatory approval, is expected to complete around Q3 2024.

 

Slaughter and May is working closely with Johnson Matthey’s in-house legal team led by Joanne Holmes and Luke Dovey.

Corporate
Andrew Jolly Partner
Paul Mudie Partner
Justin Chan Partner
Ellie Nugent Associate
Iain Meiklejohn Associate
Thomas Hurleston Associate
Sharon Law Associate

Lily Church / Barrister Secondee, Maria Michael / Trainee, Emma Russell / Trainee, Jason TL Chan / Legal Assistant

IP/IT
Duncan Blaikie Partner
Oliver Noble Associate

Edward Zheng / Visiting Lawyer

Pensions and Employment
Chris Sharpe Partner
Phil Linnard Partner
Simon Clark Associate
Will Amor Associate
Tax
Charles Osborne Partner
Kasim Mehmood Associate
Competition
Lorna Nsoatabe Partner
Tina Zhuo Partner
Sarah Drummond Associate
Real Estate
Jane Edwarde Partner - Real Estate
Emily AlHamarneh Associate
Environment
Richard Keczkes Head of Planning